Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$30.21 - $48.1 $50,571 - $80,519
1,674 Added 0.83%
203,826 $6.78 Million
Q4 2022

Jan 30, 2023

SELL
$22.28 - $38.71 $164,938 - $286,570
-7,403 Reduced 3.53%
202,152 $6.21 Million
Q3 2022

Oct 21, 2022

BUY
$34.2 - $51.69 $344,496 - $520,673
10,073 Added 5.05%
209,555 $7.17 Million
Q2 2022

Jul 26, 2022

BUY
$23.14 - $49.68 $481,242 - $1.03 Million
20,797 Added 11.64%
199,482 $6.92 Million
Q1 2022

Apr 27, 2022

SELL
$27.77 - $64.4 $330,324 - $766,038
-11,895 Reduced 6.24%
178,685 $7.86 Million
Q4 2021

Feb 02, 2022

SELL
$54.9 - $105.21 $344,497 - $660,192
-6,275 Reduced 3.19%
190,580 $12 Million
Q3 2021

Oct 25, 2021

SELL
$105.0 - $178.37 $328,545 - $558,119
-3,129 Reduced 1.56%
196,855 $20.7 Million
Q2 2021

Aug 02, 2021

BUY
$125.11 - $180.0 $2.14 Million - $3.08 Million
17,084 Added 9.34%
199,984 $35.4 Million
Q1 2021

Apr 30, 2021

BUY
$126.27 - $191.71 $426,792 - $647,979
3,380 Added 1.88%
182,900 $24.4 Million
Q4 2020

Feb 05, 2021

SELL
$81.94 - $135.34 $135,938 - $224,529
-1,659 Reduced 0.92%
179,520 $24.3 Million
Q3 2020

Oct 30, 2020

BUY
$73.3 - $89.48 $132,746 - $162,048
1,811 Added 1.01%
181,179 $15.1 Million
Q2 2020

Jul 27, 2020

BUY
$48.82 - $82.53 $815,294 - $1.38 Million
16,700 Added 10.27%
179,368 $14.7 Million
Q1 2020

Apr 27, 2020

BUY
$39.1 - $62.9 $3.71 Million - $5.96 Million
94,800 Added 139.68%
162,668 $8.37 Million
Q4 2019

Jan 31, 2020

SELL
$29.79 - $43.06 $1.52 Million - $2.19 Million
-50,946 Reduced 42.88%
67,868 $2.82 Million
Q3 2019

Oct 31, 2019

SELL
$30.47 - $37.65 $2.47 Million - $3.05 Million
-81,089 Reduced 40.56%
118,814 $3.84 Million
Q2 2019

Jul 29, 2019

BUY
$25.73 - $35.79 $33,371 - $46,419
1,297 Added 0.65%
199,903 $6.97 Million
Q1 2019

May 08, 2019

SELL
$21.71 - $31.54 $50,497 - $73,362
-2,326 Reduced 1.16%
198,606 $5.86 Million
Q4 2018

Feb 06, 2019

SELL
$14.95 - $24.72 $107,430 - $177,637
-7,186 Reduced 3.45%
200,932 $4.55 Million
Q3 2018

Nov 07, 2018

BUY
$17.8 - $25.35 $97,419 - $138,740
5,473 Added 2.7%
208,118 $4.05 Million
Q2 2018

Aug 01, 2018

SELL
$18.0 - $25.01 $14,274 - $19,832
-793 Reduced 0.39%
202,645 $4.71 Million
Q1 2018

May 01, 2018

BUY
$20.05 - $26.96 $297,281 - $399,735
14,827 Added 7.86%
203,438 $4.34 Million
Q4 2017

Feb 06, 2018

BUY
$21.23 - $34.09 $4 Million - $6.43 Million
188,611
188,611 $4 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.57B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.